CROSS COUNTRY HEALTHCARE INC (CCRN)
US2274831047 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.677B 100.47% | 2.807B 67.39% | 2.02B -28.04% | 1.367B -32.32% | 1.278B -6.51% | 1.319B 3.21% | |
| EBITDA YoY % growth | 155M 498.46% | 293.9M 89.61% | 135.516M -53.89% | 52.684M -61.12% | 51.786M -1.70% | 58.112M 12.22% | |
| EBIT YoY % growth | 145.1M 999.24% | 281.3M 93.87% | 117.169M -58.35% | 5.039M -95.70% | 25.805M 412.11% | 33.514M 29.87% | |
| Operating Margin | 8.65% | 10.02% | 5.80% | 0.37% | 2.02% | 2.54% | |
| EPS YoY % growth | 3.06 565.22% | 5.26 71.90% | 2.21 -57.98% | 0.54 -75.41% | 0.58 7.24% | 0.69 18.56% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.12 -59.55% | 0.11 -42.02% | 0.14 38.72% | 0.14 20.70% | 0.17 42.61% | 0.11 -2.78% | 0.17 25.00% | 0.18 23.24% | 0.18 9.76% |
| Revenue Q2Q % growth | 312.38M -24.55% | 311.13M -17.95% | 313.51M -7.73% | 319.8M 1.49% | 324.65M 3.93% | 326.06M 4.80% | 330.91M 5.55% | 336.8M 5.32% | 334.02M 2.89% |
| EBITDA Q2Q % growth | 12.228M -62.53% | 11.519M -9.69% | 12.94M 452.97% | 12.83M -27.56% | 14.142M 15.65% | 11.409M -0.95% | 14.744M 13.94% | 14.382M 12.10% | 14.749M 4.29% |
| EBIT Q2Q % growth | 5.658M -60.40% | 6.672M -17.76% | 6.512M 149.99% | 6.47M 68.01% | 7.571M 33.81% | 7.742M 16.04% | 9.088M 39.56% | 9.863M 52.44% | 9.71M 28.25% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.12 -69.23% | 0.10 | 0.02 | 22.23% |
| Q2 2024 Q2Q % growth | 0.10 -85.51% | 0.14 | -0.04 | -26.01% |
| Q1 2024 Q2Q % growth | 0.19 -77.38% | 0.17 | 0.02 | 8.77% |
| Q4 2023 Q2Q % growth | 0.29 -73.39% | 0.28 | 0.01 | 4.02% |
| Q3 2023 Q2Q % growth | 0.39 -63.55% | 0.42 | -0.03 | -6.09% |
| Q2 2023 Q2Q % growth | 0.69 -50.71% | 0.62 | 0.07 | 11.06% |
| Q1 2023 Q2Q % growth | 0.84 -50.59% | 0.76 | 0.08 | 10.21% |
| Q4 2022 Q2Q % growth | 1.09 -22.14% | 0.91 | 0.18 | 19.49% |
| Q3 2022 Q2Q % growth | 1.07 75.41% | 0.97 | 0.10 | 10.36% |
| Q2 2022 Q2Q % growth | 1.40 197.87% | 1.38 | 0.02 | 1.78% |
| Q1 2022 Q2Q % growth | 1.70 193.10% | 1.34 | 0.36 | 26.81% |
| Q4 2021 Q2Q % growth | 1.40 636.84% | 1.27 | 0.13 | 10.40% |
| Q3 2021 Q2Q % growth | 0.61 408.33% | 0.35 | 0.26 | 73.53% |
| Q2 2021 Q2Q % growth | 0.47 193.75% | 0.40 | 0.07 | 16.36% |
| Q1 2021 Q2Q % growth | 0.58 5,900.00% | 0.35 | 0.23 | 66.57% |
| Q4 2020 Q2Q % growth | 0.19 171.43% | 0.09 | 0.10 | 117.23% |
| Q3 2020 Q2Q % growth | 0.12 140.00% | -0.03 | 0.15 | 500.43% |
| Q2 2020 Q2Q % growth | 0.16 1,500.00% | -0.03 | 0.19 | 581.62% |
| Q1 2020 Q2Q % growth | -0.01 -150.00% | -0.02 | 0.01 | 40.83% |
| Q4 2019 Q2Q % growth | 0.07 | 0.06 | 0.01 | 18.61% |
| Q3 2019 Q2Q % growth | 0.05 | 0.01 | 0.04 | 289.97% |
| Q2 2019 Q2Q % growth | 0.01 | 0.00 | 0.01 | 328.53% |
| Q1 2019 Q2Q % growth | 0.02 | -0.04 | 0.06 | 152.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 315.119M -28.75% | 316.42M | -1.301M | -0.41% |
| Q2 2024 Q2Q % growth | 339.771M -37.16% | 341.45M | -1.679M | -0.49% |
| Q1 2024 Q2Q % growth | 379.174M -39.11% | 381.57M | -2.396M | -0.63% |
| Q4 2023 Q2Q % growth | 414.035M -34.09% | 412.51M | 1.525M | 0.37% |
| Q3 2023 Q2Q % growth | 442.291M -30.47% | 452.78M | -10.489M | -2.32% |
| Q2 2023 Q2Q % growth | 540.695M -28.25% | 542.31M | -1.615M | -0.30% |
| Q1 2023 Q2Q % growth | 622.707M -21.05% | 606.9M | 15.807M | 2.60% |
| Q4 2022 Q2Q % growth | 628.2M -1.95% | 606.46M | 21.74M | 3.58% |
| Q3 2022 Q2Q % growth | 636.1M 69.67% | 629.89M | 6.21M | 0.99% |
| Q2 2022 Q2Q % growth | 753.6M 127.12% | 755.75M | -2.15M | -0.28% |
| Q1 2022 Q2Q % growth | 788.7M 139.58% | 760.55M | 28.15M | 3.70% |
| Q4 2021 Q2Q % growth | 640.7M 197.17% | 627.56M | 13.14M | 2.09% |
| Q3 2021 Q2Q % growth | 374.9M 93.25% | 326.88M | 48.02M | 14.69% |
| Q2 2021 Q2Q % growth | 331.8M 53.04% | 303.29M | 28.51M | 9.40% |
| Q1 2021 Q2Q % growth | 329.2M 56.69% | 294.98M | 34.22M | 11.60% |
| Q4 2020 Q2Q % growth | 215.6M 0.23% | 200.35M | 15.25M | 7.61% |
| Q3 2020 Q2Q % growth | 194M -7.27% | 178.06M | 15.94M | 8.95% |
| Q2 2020 Q2Q % growth | 216.8M 6.90% | 202.87M | 13.93M | 6.87% |
| Q1 2020 Q2Q % growth | 210.1M 7.63% | 214.22M | -4.12M | -1.92% |
| Q4 2019 Q2Q % growth | 215.1M | 212.39M | 2.71M | 1.28% |
| Q3 2019 Q2Q % growth | 209.2M | 206.71M | 2.49M | 1.20% |
| Q2 2019 Q2Q % growth | 202.8M | 203.39M | -590K | -0.29% |
| Q1 2019 Q2Q % growth | 195.2M | 203.15M | -7.95M | -3.91% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -63.78% | 0.22% | 2.97% |
| Revenue | 0% | -19.11% | 0% | -0.65% |